Soligenix, Inc.
Pharmaceutical Preparations · Princeton, NJ, United States
- PrincipalsChristopher J SchaberCHAIRMAN, CEO AND PRESIDENTJonathan L. GuarinoCFORichard StraubeCMO (Consulting)and 1 more
- CompanySoligenix, Inc.Princeton, NJ, United States
- Phone line+1 (609) 538-8200General business
Soligenix, Inc. is an SEC-registered Nasdaq-listed company (ticker SNGX) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 4
Chief executive
Christopher J SchaberCHAIRMAN, CEO AND PRESIDENT
Finance
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Christopher J Schaber — CHAIRMAN, CEO AND PRESIDENT
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jonathan L. Guarino — CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Richard Straube — CMO (Consulting)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Oreola Donini — CSO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Silence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capability